Fundraising Fox
/Companies
Sign in

MarvelBiome

Woburn, US · Founded 2019 · Delaware corporation · 2 known investors

Find your way into MarvelBiome

Sign up to see every warm intro you have to MarvelBiome

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the MarvelBiome team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

MarvelBiome is a clinical-stage biotechnology company developing Live Biotherapeutic Products through engineered bacterial consortia designed to treat disease-specific conditions. The company focuses on microbiome-based treatments for patients.

BiotechHealthtechMedical DevicesWellness & Fitness

Founders & leadership

EJ
Elamparithi JayamaniChief Technology OfficerHe has research expertise in microbiology, microbiome science, host-microbe interactions, and high-throughput assay development.
JAJ. Amaranath Govindan
J. Amaranath GovindanPresident and Chief Scientific Officer
PC
Priti ChatterNamed on SEC filing
MC
Mukesh ChatterNamed on SEC filing

Board

GZ
G. Zachary GundBoard director
GR
Gary RuvkunBoard director
RE
Rudolph E. TanziBoard director

Investors · 2

Walden InternationalreportedSan Francisco

How we know: funding news · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$54.9M disclosed across 4 rounds · 2020–2025

▶$39.6MraisedOct 2025 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Priti ChatterDirector
  • G. Zachary GundDirector
  • Elamparithi JayamaniExecutive Officer
  • Gary RuvkunDirector
  • Mukesh ChatterDirector
  • Rudolph E. TanziDirector
  • J. Amaranath GovindanExecutive Officer, Director
Offering amount
$52.5M
Amount sold
$39.6M
First sale
Oct 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10MraisedAug 2023 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Gary RuvkunDirector
  • Rudolph TanziDirector
  • Elamparithi JayamaniExecutive Officer
  • Jothi Amaranath GovindanExecutive Officer, Director
  • Priti ChatterDirector
  • Mukesh ChatterDirector
Offering amount
$10M
Amount sold
$10M
First sale
Jul 2023
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.1MraisedNov 2020 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Elamparithi JayamaniExecutive Officer
  • Jothi Amaranath GovindanExecutive Officer, Director
  • Priti ChatterDirector
  • Rudolph TanziDirector
  • Gary RuvkunDirector
  • Mukesh ChatterDirector
Offering amount
$20M
Amount sold
$3.1M
First sale
Nov 2020
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.3MraisedJun 2020 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jothi Amaranath GovindanExecutive Officer, Director
  • Elamparithi JayamaniExecutive Officer
  • Mukesh ChatterDirector
  • Rudolph E. TanziDirector
  • Priti ChatterDirector
  • Gary RuvkunDirector
Offering amount
$2.3M
Amount sold
$2.3M
First sale
Jun 2020
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 8

Holobiome, Inc.Holobiome discovers and develops therapies derived from the human gut microbiome, working to translate microbiome science into probiotics and targeted treatments for whole-body health. The company was founded by research scientists from Northeastern University.
BIOHMBIOHM sells probiotic supplements and at-home gut test kits that analyze the microbiome, with results reviewed by a microbiome-trained registered nutritionist who provides personalized diet and supplement recommendations. Its formula combines bacteria, fungi, and a digestive enzyme intended to support digestive health.
BiomeSenseBiomeSense builds an AI-enabled platform combining hardware (GutLab) and bioinformatics (MetaBiome) to continuously generate and analyze gut microbiome data. It serves scientists, institutions, and companies conducting clinical research on the microbiome for personalized biomarker discovery and product development.
Biome AnalyticsBiome provides analytics tools for healthcare leaders, focused on improving cardiovascular care outcomes and reducing operational inefficiency. It serves hospitals and cardiac care centers, offering data-driven products including the Biome Performance Network for clinical and operational decision-making.
Viome Life SciencesViome offers at-home tests that analyze the gut and oral microbiome plus cellular blood samples using mRNA/metatranscriptomic sequencing, returning 70+ health scores (including biological age and inflammation) and personalized food and supplement recommendations. The direct-to-consumer service, analyzed in a CLIA-certified lab, is aimed at individuals seeking insights into digestion, metabolism, and overall wellness.
PendulumPendulum is a probiotic and prebiotic supplement company that develops clinically-tested products targeting gut health, metabolic function, and glucose control, including proprietary strains like live Akkermansia.
AgbiomeUS agricultural biotech that discovered microbe-based crop protection products; its assets were sold to Certis Biologicals and Ginkgo Bioworks in 2024.
EquityZenEquityZen operates an online marketplace that gives accredited individual investors access to shares in late-stage private companies through secondary market transactions. Now part of Morgan Stanley, the platform provides private market data, offering documents, and guided investment processes for buying and selling pre-IPO equity.

Companies working in the same space as MarvelBiome.

Frequently asked questions

What does MarvelBiome do?
MarvelBiome is a clinical-stage biotechnology company developing Live Biotherapeutic Products through engineered bacterial consortia designed to treat disease-specific conditions. The company focuses on microbiome-based treatments for patients.
Who are MarvelBiome's investors?
MarvelBiome's investors include PHD Ventures, Walden International.
How much funding has MarvelBiome raised?
MarvelBiome has disclosed $54.9M raised across 4 rounds.
Where is MarvelBiome headquartered?
MarvelBiome is headquartered in Woburn, US.